These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 33708864

  • 1. Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment.
    Hu K, Yuan J, Tang B, Zhang F, Lu S, Chen R, Zhang L, Ren Z, Yin X.
    Ann Transl Med; 2021 Feb; 9(3):237. PubMed ID: 33708864
    [Abstract] [Full Text] [Related]

  • 2. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Hansmann J, Evers MJ, Bui JT, Lokken RP, Lipnik AJ, Gaba RC, Ray CE.
    J Vasc Interv Radiol; 2017 Sep; 28(9):1224-1231.e2. PubMed ID: 28688815
    [Abstract] [Full Text] [Related]

  • 3. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
    Ananchuensook P, Sriphoosanaphan S, Suksawatamnauy S, Siripon N, Pinjaroen N, Geratikornsupuk N, Kerr SJ, Thanapirom K, Komolmit P.
    BMC Gastroenterol; 2022 Jun 14; 22(1):295. PubMed ID: 35701739
    [Abstract] [Full Text] [Related]

  • 4. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.
    Lee SK, Song MJ, Kim SH, Park M.
    PLoS One; 2019 Jun 14; 14(5):e0216173. PubMed ID: 31048923
    [Abstract] [Full Text] [Related]

  • 5. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
    Liu PH, Hsu CY, Hsia CY, Lee YH, Chiou YY, Huang YH, Lee FY, Lin HC, Hou MC, Huo TI.
    J Gastroenterol Hepatol; 2017 Apr 14; 32(4):879-886. PubMed ID: 27696519
    [Abstract] [Full Text] [Related]

  • 6. Comparison of albumin-bilirubin grade versus Child-Pugh score in predicting the outcome of transarterial chemoembolization for hepatocellular carcinoma using time-dependent ROC.
    Zhao S, Zhang T, Li H, Wang M, Xu K, Zheng D, Du X, Liu L.
    Ann Transl Med; 2020 Apr 14; 8(8):538. PubMed ID: 32411761
    [Abstract] [Full Text] [Related]

  • 7. Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY, Fang ZT, An C, Sun HL, Huang ZM, Zhang TQ, Jiang XY, Chen YT, Xu LF, Huang JH.
    Int J Hyperthermia; 2019 Apr 14; 36(1):841-853. PubMed ID: 31452408
    [Abstract] [Full Text] [Related]

  • 8. Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT).
    Ho CHM, Chiang CL, Lee FAS, Choi HCW, Chan JCH, Yeung CSY, Huang JJ, Chan MKH, Blanck O, Wong FCS.
    Oncotarget; 2018 Jun 22; 9(48):28818-28829. PubMed ID: 29988960
    [Abstract] [Full Text] [Related]

  • 9. Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma.
    Wang Z, Fan Q, Wang M, Wang E, Li H, Liu L.
    Ann Transl Med; 2020 Apr 22; 8(8):537. PubMed ID: 32411760
    [Abstract] [Full Text] [Related]

  • 10. Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic.
    Tada T, Kumada T, Toyoda H, Tsuji K, Hiraoka A, Michitaka K, Deguchi A, Ishikawa T, Imai M, Ochi H, Joko K, Shimada N, Tajiri K, Hirooka M, Koizumi Y, Hiasa Y, Tanaka J.
    J Gastroenterol Hepatol; 2019 Jun 22; 34(6):1066-1073. PubMed ID: 30549320
    [Abstract] [Full Text] [Related]

  • 11. Albumin-bilirubin and platelet-albumin-bilirubin grades for hepatitis B-associated hepatocellular carcinoma in Child-Pugh A patients treated with radical surgery: A retrospective observational study.
    Wu B, Hu X, Jin H, Zhou L, Zhang D, Man Z, Wang Y, Yang S, Pang Q, Liu H, Cui P.
    Medicine (Baltimore); 2019 Oct 22; 98(43):e17394. PubMed ID: 31651841
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis.
    Oikonomou T, Goulis L, Doumtsis P, Tzoumari T, Akriviadis E, Cholongitas E.
    Ann Hepatol; 2019 Oct 22; 18(1):126-136. PubMed ID: 31113581
    [Abstract] [Full Text] [Related]

  • 18. Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy.
    Cai XR, Chen ZH, Liu MM, Lin JX, Zhang XP, Chen J, Lin Q, Ma XK, Wen JY, Xie SD, Wu XY, Dong M.
    J Cancer; 2018 Oct 22; 9(13):2380-2388. PubMed ID: 30026834
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of pretreatment albumin-bilirubin (ALBI) grade and platelet-albumin-bilirubin (PALBI) grade in patients with small cell lung cancer.
    Kut E, Menekse S.
    Sci Rep; 2024 Jan 16; 14(1):1371. PubMed ID: 38228667
    [Abstract] [Full Text] [Related]

  • 20. Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Young LB, Tabrizian P, Sung J, Biederman D, Bishay VL, Ranade M, Patel RS, Nowakowski FS, Fischman AM, Lookstein RA, Kim E.
    J Vasc Interv Radiol; 2022 May 16; 33(5):510-517.e1. PubMed ID: 35150838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.